Unlike mutated BRaf, aberrant Grm1 expression in melanocytes is sufficient to induce cell transformation in vitro and robust tumor formation in vivo with no alteration in p15 expression and almost undetectable TGFβ. Here, CDKN2B is linked to neoplasm.